BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19405793)

  • 1. Treatment strategies for cystic fibrosis: what's in the pipeline?
    Frerichs C; Smyth A
    Expert Opin Pharmacother; 2009 May; 10(7):1191-202. PubMed ID: 19405793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Evolution of Cystic Fibrosis Care.
    Pittman JE; Ferkol TW
    Chest; 2015 Aug; 148(2):533-542. PubMed ID: 25764168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in cystic fibrosis therapies.
    Rowe SM; Clancy JP
    Curr Opin Pediatr; 2006 Dec; 18(6):604-13. PubMed ID: 17099358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment options for cystic fibrosis: state of the art and future perspectives.
    Sears EH; Gartman EJ; Casserly BP
    Rev Recent Clin Trials; 2011 May; 6(2):94-107. PubMed ID: 21241236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New and emerging therapies for pulmonary complications of cystic fibrosis.
    Tonelli MR; Aitken ML
    Drugs; 2001; 61(10):1379-85. PubMed ID: 11558827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving complex medical care while awaiting next-generation CFTR potentiators and correctors: The current pipeline of therapeutics.
    Goralski JL; Davis SD
    Pediatr Pulmonol; 2015 Oct; 50 Suppl 40():S66-73. PubMed ID: 26335956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies.
    Kreindler JL
    Pharmacol Ther; 2010 Feb; 125(2):219-29. PubMed ID: 19903491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches.
    Ghigo A; Prono G; Riccardi E; De Rose V
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatories and mucociliary clearance therapies in the age of CFTR modulators.
    Perrem L; Ratjen F
    Pediatr Pulmonol; 2019 Nov; 54 Suppl 3():S46-S55. PubMed ID: 31715088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging treatments in cystic fibrosis.
    Jones AM; Helm JM
    Drugs; 2009 Oct; 69(14):1903-10. PubMed ID: 19747007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging therapies in cystic fibrosis.
    Anderson P
    Ther Adv Respir Dis; 2010 Jun; 4(3):177-85. PubMed ID: 20530065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on clinical trials of cystic fibrosis.
    Henig NR; Aitken ML
    Curr Opin Pulm Med; 1997 Nov; 3(6):404-9. PubMed ID: 9391758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging drugs for cystic fibrosis.
    Amin R; Ratjen F
    Expert Opin Emerg Drugs; 2014 Mar; 19(1):143-55. PubMed ID: 24479826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients.
    Amaral MD
    J Intern Med; 2015 Feb; 277(2):155-166. PubMed ID: 25266997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on new pulmonary therapies.
    Retsch-Bogart GZ
    Curr Opin Pulm Med; 2009 Nov; 15(6):604-10. PubMed ID: 19696677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model of mucociliary clearance in cystic fibrosis lungs.
    Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
    J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively?
    Tiddens HA; Donaldson SH; Rosenfeld M; Paré PD
    Pediatr Pulmonol; 2010 Feb; 45(2):107-17. PubMed ID: 20082341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New therapies for cystic fibrosis.
    Simakajornboon N; Davis SH
    J La State Med Soc; 1998 Dec; 150(12):629-37. PubMed ID: 9926704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis: a review of pulmonary and nutritional therapies.
    Amin R; Ratjen F
    Adv Pediatr; 2008; 55():99-121. PubMed ID: 19048729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From pipeline to patient: new developments in cystic fibrosis therapeutics.
    Prayle AP; Smyth AR
    Expert Opin Pharmacother; 2013 Feb; 14(3):323-9. PubMed ID: 23374028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.